Gene test could predict heart attack and stroke risk
NCT ID NCT06855394
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study examines whether a common gene variation (CYP2C19) influences the long-term risk of serious heart and blood vessel events, such as heart attacks, strokes, and limb problems, in people with vascular disease. Researchers will analyze genetic and health data from 13,000 patients at the University of Florida. The goal is to better understand how genetics affect treatment outcomes, not to test a new treatment.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for ATHEROSCLEROSIS OF ARTERIES OF THE EXTREMITIES, UNSPECIFIED are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
UF Health
Gainesville, Florida, 32608, United States
-
UF Health
Jacksonville, Florida, 32209, United States
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Spinal zaps could reboot breathing after brain injury
- Can brain scans reveal hidden language struggles after stroke?
- Can lifestyle choices after a stroke extend life and prevent a second one?
- A tablet test aims to catch hidden attention and memory problems after stroke
- Can a gentle ear zap supercharge stroke rehab at home?
- Can exercise boost reading recovery in stroke survivors?